share_log

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Duker Jay S.

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Duker Jay S.

EyePoint Pharmaceuticals | 4：持股變動聲明-高管 Duker Jay S.
美股SEC公告 ·  07/13 05:08
牛牛AI助理已提取核心訊息
EyePoint Pharmaceuticals, Inc. (EYPT) President and CEO, Jay S. Duker, completed a stock transaction on July 10, 2024. Duker exercised options to acquire 16,666 shares of common stock at no cost and subsequently sold 8,059 shares at a price of $8.69 per share. The total market value of the disposed shares amounted to $70,032.71. Following these transactions, Duker directly holds 38,027 shares of EyePoint Pharmaceuticals. Additionally, an indirect holding of 22,500 shares is maintained by a family trust.
EyePoint Pharmaceuticals, Inc. (EYPT) President and CEO, Jay S. Duker, completed a stock transaction on July 10, 2024. Duker exercised options to acquire 16,666 shares of common stock at no cost and subsequently sold 8,059 shares at a price of $8.69 per share. The total market value of the disposed shares amounted to $70,032.71. Following these transactions, Duker directly holds 38,027 shares of EyePoint Pharmaceuticals. Additionally, an indirect holding of 22,500 shares is maintained by a family trust.
EyePoint Pharmaceuticals公司總裁兼首席執行官Jay S. Duker在2024年7月10日完成了股票交易。 Duker行使期權，免費獲得了16666股普通股，並以每股8.69美元的價格出售了8059股。 拋售股票的總市值爲70,032.71美元。 在這些交易之後，Duker直接持有EyePoint Pharmaceuticals公司的38,027股股票。 此外，家庭信託還保留有22,500股的間接持股。
EyePoint Pharmaceuticals公司總裁兼首席執行官Jay S. Duker在2024年7月10日完成了股票交易。 Duker行使期權，免費獲得了16666股普通股，並以每股8.69美元的價格出售了8059股。 拋售股票的總市值爲70,032.71美元。 在這些交易之後，Duker直接持有EyePoint Pharmaceuticals公司的38,027股股票。 此外，家庭信託還保留有22,500股的間接持股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。